SCHEMBL7367450

SCHEMBL7367450

CC(C)(CCc1ccccc1)c1cc(O)c(C(c2cccc(NS(=O)(=O)c3ccccc3)c2)C2CC2)c(=O)o1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 7/20 0.38
MAP1LC3B Q9GZQ8 1/20 0.37
MAP1LC3A Q9H492 1/20 0.37
PTGES O14684 1/20 0.37
TGFBR1 P36897 2/20 0.37
SLC2A1 P11166 1/20 0.36
IKBKB O14920 1/20 0.35
CTSD P07339 2/20 0.35
BACE1 P56817 1/20 0.35
BACE2 Q9Y5Z0 1/20 0.35
ADRB3 P13945 1/20 0.34
MLNR O43193 1/20 0.33
NR1I2 O75469 1/20 0.33
ABCB11 O95342 1/20 0.33
PGR P06401 1/20 0.33
CHRM2 P08172 1/20 0.33
ADRA2A P08913 1/20 0.33
PGA5 P0DJD9 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
CTSE P14091 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7367288 0.92 PTGES (0.38) HTR6MAP1LC3BMAP1LC3APTGESTGFBR1
SCHEMBL8539266 0.92 HDAC8 (0.37) HTR6MAP1LC3BMAP1LC3ATGFBR1NR1I2
SCHEMBL7407674 0.91 HTR6 (0.37) HTR6MAP1LC3BMAP1LC3APTGESTGFBR1
SCHEMBL7371141 0.86 TGFBR1 (0.38) HTR6PTGESTGFBR1IKBKBFABP4
SCHEMBL7368440 0.86 PTGES (0.37) HTR6MAP1LC3BMAP1LC3APTGESTGFBR1
SCHEMBL7405494 0.85 CNR1 (0.33) OPRD1
SCHEMBL7378472 0.84 TGFBR1 (0.36) HTR6MAP1LC3BMAP1LC3APTGESTGFBR1
SCHEMBL8539904 0.84 GHSR (0.37) MAP1LC3BMAP1LC3ATGFBR1NR1I2FABP4
SCHEMBL8534806 0.82 HDAC8 (0.36) HTR6MAP1LC3BMAP1LC3ATGFBR1SLC2A1
SCHEMBL7373124 0.82 HTR6 (0.38) HTR6MAP1LC3BMAP1LC3APTGESSLC2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729465-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP claimed
WO-1995014013-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO claimed
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
EP-0729465-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014013-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed